Search
Close this search box.
Search

Unique amyloid buildup in brain blood vessel offers clue to Alzheimer’s development

Accumulating amounts of amyloid - a fragment of a larger protein - in the brain have been associated before with the development of dementia, including Alzheimer’s disease. A team of neuroscience and biochemistry researchers at Stony Brook University have now made a discovery that illustrates for the first time the difference between amyloid buildup in brain blood vessels and amyloid buildup around brain neurons. Their findings may provide a new path to research on Alzheimer’s disease and its cause.

Lead investigator in the study William Van Nostrand, PhD, a professor in the Department of Neurosurgery, says the findings stem from collaborative work with Steven Smith, PhD, a professor in the Department of Biochemistry & Cell Biology. Together with colleagues from both departments they have  mapped out the structural signature of amyloid that accumulates in brain blood vessels and compared it to the known structure of amyloid that accumulate in plaque around brain neurons.

Unique and alternating patterns

The team found that the subunits of the amyloid that accumulates in vessels line up uniquely and in alternating patterns, which presents in a near opposite pattern of amyloid buildup in plaque around neurons. “This discovery may help guide us to the development of a new diagnostic tool or therapeutic intervention for dementia patients who display this vessel pathology,” summarized Dr. Van Nostrand.
The study hypothesizes that the unique structure of this brain blood vessel amyloid could promote different pathological responses, ie, inflammation, which likely contributes differently to cognitive impairment and dementia than neuron amyloid.

Rates of dementia dropping in U.S.

In other research published online in JAMA Internal Medicine,  evidence suggests that rates of dementia across the United States are dropping. This could be because healthier behavior defers the onset of age-related dementia such as Alzheimer’s disease, as well as cancer, stroke and heart disease, the study states. Based on surveys of more than 20,000 individuals, the percentage of individuals 65 years or older with dementia declined from 11.6 percent in 2000 to 8.8 percent in 2012. The study was based on a nationally representative, population-based survey of individuals in the U.S.

Healthier behavior

Robert Friedland, M.D., professor of neurology at the University of Louisville School of Medicine,  attributes this reduction to healthier behaviors that defer onset of age-related dementia. Friedland studies brain disorders associated with aging and treats patients at University of Louisville Physicians.

“This work supports the past 20+ years of my research that has shown that it is possible to lower the risk of getting dementia with age. Lifestyle choices have consequences for the risk of Alzheimer’s disease, as well as cancer, stroke and heart disease,” Friedland said. “The reason that rates of dementia are declining is that people are living healthier lives than before.”

Whixx

ICT&health World Conference 2024

Experience the future of healthcare at the ICT&health World Conference from May 14th to 16th, 2024!
Secure your ticket now and immerse yourself in groundbreaking technologies and innovative solutions.
Engage with fellow experts and explore the power of global collaborations.

Share this article!

Read also
Mayo Clinic started with its innovations for its ten million patients and demonstrated that its model worked, and that data could be ethically and responsibly used to drive innovations.
John Halamka: 'Create the Fear of Missing Out'
Balancing regulatory compliance with seamless adoption, healthcare navigates the integration of AI solutions.
A guide to implementing AI in healthcare amid the EU AI Act
AmyWebb-Stephen-Olker
Futurist Amy Webb claims that wearables will evolve into "connectables"
Digital health solutions empower patients to better manage their health and integrate care into their daily lives.
How to improve Digital Patient Engagement to streamline workflows
For people with diabetes, inaccurate blood glucose measurements can lead to errors in diabetes management, including taking the wrong dose of insulin, sulfonylureas, or other medications that can rapidly lower blood glucose.
Smartwatches measuring glucose level: Harmful but easy to buy fake innovations
How to introduce innovation and AI in healthcare organizations if there is no business model for prevention and quality – Our interview with Professor Ran Balicer, the Chief Innovation Officer at Clalit Health Services and founding Director of Clalit Research Institute.
I see no legitimate rationale for delaying the digital transformation in healthcare
Pioneering Cardiac Arrest Detection for Enhanced Survival.
CardioWatch Revolutionizes Cardiac Arrest Detection
Dr. Oscar Díaz-Cambronero, Head of Perioperative Medicine Department at La Fe Hospital, spearheads innovative telemonitoring initiatives revolutionizing patient care
Smartwatches Saving Lives Inside and Outside the Hospital
EIT 2024
EIT Awards 2024. Two European startups are revolutionizing the treatment of cardiovascular diseases
Bertrand Piccard, Swiss explorer and founder of the Solar Impulse Foundation
EIT Summit 2024. What are the trigger points that drive or inhibit innovation?
Follow us